U.S. Tobacco Stock News

NYSE:VLTO
NYSE:VLTOCommercial Services

Did Veralto’s (VLTO) Q2 Buybacks and Alfaa UV Deal Just Reframe Its Capital Playbook?

In the second quarter of 2026, Veralto Corporation reported higher sales of US$1,474 million and net income of US$241 million year over year, while also completing a US$433.5 million share repurchase program and announcing the acquisition of India-based UV water treatment specialist Alfaa UV. Management emphasized that mergers and acquisitions remain the primary use of capital, highlighting an active deal pipeline and the Alfaa UV bolt-on as a way to strengthen Veralto’s water treatment...
NYSE:HCC
NYSE:HCCMetals and Mining

Warrior Met Coal (HCC) Updates 2026 Guidance, Is It Still Below Fair Value?

Warrior Met Coal (HCC) is back in focus after its 5 August 2026 earnings release. The company reported updated quarterly results, revised full year 2026 volume guidance, new production targets, and a reaffirmed cash dividend. See our latest analysis for Warrior Met Coal. Warrior Met Coal’s latest earnings and higher 2026 volume guidance have come alongside strong price momentum, with a 7 day share price return of 15.82% and a 1 year total shareholder return of 51.87% pointing to rising...
NasdaqGS:MNST
NasdaqGS:MNSTBeverage

Why Monster Beverage (MNST) Is Down 6.2% After Stronger First-Half 2026 Earnings Performance And What's Next

Monster Beverage Corporation reported past second-quarter 2026 results with sales of US$2,537.47 million and net income of US$584.54 million, alongside higher basic and diluted earnings per share from continuing operations compared with a year earlier. Across the first half of 2026, the company lifted sales to US$4,890.76 million and net income to US$1,154.03 million, suggesting operating performance that may feed into how investors assess its expansion efforts and cost management. Now, we...
NYSE:MP
NYSE:MPMetals and Mining

MP Materials (MP) Is Up 23.5% After Stronger NdPr Output And New Defense Deal - Has The Bull Case Changed?

MP Materials Corp. has already reported second-quarter 2026 results, with sales rising to US$108.49 million from US$57.39 million a year earlier and its net loss narrowing to US$20.3 million, alongside higher NdPr output and progress on magnet manufacturing and heavy rare-earth separation. The company’s new multiyear gadolinium oxide supply deal with a U.S. aerospace and defense customer, combined with advancing domestic magnet production, could further entrench its role in U.S. critical...
NYSE:CVX
NYSE:CVXOil and Gas

Chevron (CVX) Stock May Still Look Reasonable Despite Its 125% Run

Chevron stock has delivered a very strong 5 year run, yet current checks suggest the market price may still sit below what recent cash flow and earnings based valuations imply. A 124.6% total return over the past 5 years indicates that Chevron has already created substantial shareholder value, so any further upside case now rests on how durable that earnings power proves to be. Chevron's growing role in supplying power and fuel to AI data centers can support expectations for long term cash...
NYSE:CRM
NYSE:CRMSoftware

Is Salesforce (CRM) Undervalued After Its Leadership Change And AI Momentum?

Salesforce (CRM) has entered a new chapter in its leadership structure after announcing that Srini Tallapragada will step down as President and Chief Engineering and Customer Success Officer and will shift to a year-long Special Advisor role. See our latest analysis for Salesforce. Recent news around Agentforce winning a U.S. Army Human Resources Command deployment and Salesforce presenting its AI data capabilities comes as the stock shows a 30 day share price return of 18.01%, yet its 1 year...
NasdaqCM:PCT
NasdaqCM:PCTChemicals

PureCycle Technologies (PCT) Could Be 20% Overvalued On Cautious Q2 Earnings Reaction

PureCycle Technologies (PCT) is back in focus after its Q2 2026 earnings report on 6 August, which combined higher reported sales and record production with a continued net loss and cautious investor reaction. See our latest analysis for PureCycle Technologies. The Q2 2026 report came after a tough stretch for PureCycle Technologies, with the share price down 19.44% year to date and the 1 year total shareholder return down 41.62%. The recent 1 day share price return of 4.95% and 7 day share...
NasdaqCM:NODK
NasdaqCM:NODKInsurance

NI Holdings (NODK) Stock Faces Valuation Scrutiny After Profit Nearly Vanishes

NI Holdings stock barely moved after earnings, with a 0.5% gain that suggests investors shrugged at the headline. That calm reaction contrasts with a quarterly profit line that almost vanished. Basic earnings per share for Q2 came in around flat at just over US$0.01, following a far stronger start to 2026. The key issue for NI Holdings now appears to be sentiment. The stock carries a trailing P/E of 40.8x while net profit margin sits under 3%. That mix raises a clear question for investors...
NasdaqGS:SNDX
NasdaqGS:SNDXBiotechs

Syndax Pharmaceuticals (SNDX) Stock Looks Stretched As Its 63% Run Continues

Syndax Pharmaceuticals has delivered a 63.5% gain over the past year, yet the broader valuation checks and current market multiples suggest the stock is not an obvious bargain at today’s price of US$20.40. The 63.5% one year return points to strong recent optimism already reflected in Syndax Pharmaceuticals' share price. Progress on its oncology pipeline and upcoming clinical data can support expectations for future revenue, while the execution and clinical risks around those same programs...
NasdaqGS:AMKR
NasdaqGS:AMKRSemiconductor

Amkor Technology (AMKR) Reports Stronger Results And Guidance, Is It Still A Bargain?

Amkor Technology (AMKR) has drawn fresh attention after reporting second quarter 2026 results with higher sales and net income than a year earlier, alongside third quarter guidance that points to further earnings strength. See our latest analysis for Amkor Technology. Amkor Technology's recent earnings and guidance arrived alongside a mixed share price pattern, with a 10.83% 7 day share price gain following a period where the 30 day and 90 day share price returns declined 21.57% and 27.93%...
NYSE:VZ
NYSE:VZTelecom

Will Pet Tracking Integration Into Verizon’s Family App Deepen Its Connected Home Strategy (VZ)?

In early August 2026, Fi Inc. and Verizon Communications integrated the Fi Mini pet tracker into the Verizon Family app, creating a unified safety dashboard that extends real-time location, activity monitoring, and safe‑zone alerts from family members to pets within a single platform for Verizon postpaid customers. This collaboration highlights Verizon’s effort to deepen its role in the connected home by folding pets into the same digital safety ecosystem as people, potentially increasing...
NYSE:GLOB
NYSE:GLOBIT

Globant’s New Glob.AI Output Model Might Change The Case For Investing In Globant (GLOB)

Earlier this week, Globant launched Glob.AI, an AI-native tech services model delivering enterprise-grade AI Pods with output-based pricing, governance controls, and partnerships spanning Anthropic, AWS, OpenAI, Adobe, Azure, Google Cloud Platform, SAP and Salesforce. The move shifts Globant further toward an AI-centered, outcome-based services platform, with AI Pods already showing material efficiency gains for large clients like FIFA, LALIGA, YPF, PharmaMar and a major commercial...
NYSE:HMN
NYSE:HMNInsurance

Does Stronger P&C Margins And Higher Guidance Change The Bull Case For Horace Mann Educators (HMN)?

In early August 2026, Horace Mann Educators Corporation reported second-quarter revenue of US$443.5 million and net income of US$41.6 million, both higher than a year earlier, alongside record core earnings and an increased 2026 core earnings guidance range of US$4.60–US$4.90 per share. The company also highlighted sharply improved property-and-casualty profitability, with a stronger combined ratio, and announced acquisitions expected to add meaningfully to annual run-rate earnings per share...
NasdaqGS:SRAD
NasdaqGS:SRADHospitality

Gig Economy Stocks In Focus As Regulators Test Flexible Work Models

Gig economy platforms are back in the spotlight as regulators question how flexible work should really function, and that tension is putting stocks linked to this model under fresh scrutiny. For investors, that mix of legal risk and business growth can create sharp shifts in sentiment that reward those who are prepared. This article unpacks three stocks exposed to the latest gig work headlines and explains how the current scrutiny might shape their risk and return profiles. The stocks covered...
NasdaqGS:WEN
NasdaqGS:WENHospitality

Wendy's (WEN) Stock Bounce Meets Falling Traffic And Thinner Margins

Wendy’s stock bounced about 4% to US$7.69 into the first full trading day after earnings, even as the headline story is pressure, not comfort. Same restaurant sales declined 6.3% in the quarter and global systemwide sales fell 6.5%. That mix of a cheaper stock on an earnings pop and falling traffic is what matters for you as an investor. In the near term, the focus is on weaker guest counts and a thinner 5.7% trailing net margin. Over the longer term, the key question is whether the new...
NYSE:BRK.B
NYSE:BRK.BDiversified Financial

Is Berkshire Hathaway (BRK.B) Still Undervalued At $521.80?

Recent performance snapshot for Berkshire Hathaway stock Berkshire Hathaway (BRK.B) has drawn fresh attention after its share price closed at US$521.80 on 6 August 2026. The stock shows mixed short term moves, with a small daily decline and gains over the past week. Over the past month and past 3 months, Berkshire Hathaway has delivered positive total returns, along with gains over the year to date and past year. Longer term figures over the past 3 years and 5 years also show positive total...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Atlassian (TEAM) Is Up 47.6% After Profitable Quarter, Cloud-AI Momentum, and CEO Share-Buy Plan

In early August 2026, Atlassian reported fourth-quarter and full-year results showing revenue rising to US$1,766.47 million for the quarter and US$6.57 billion for the year, alongside a shift from a quarterly loss to a quarterly profit and new guidance calling for approximately 13% total revenue growth in fiscal 2027. The company also highlighted accelerating cloud and AI adoption, announced CEO Mike Cannon-Brookes’ plan to purchase up to US$250 million of Atlassian shares, and appointed Ken...
NYSE:MANU
NYSE:MANUEntertainment

Manchester United Stock And Other Sports Picks Drawing Big Money

The fight over Fifa’s abandoned $4.2b World Cup stake has drawn attention to something bigger. Tech investors are hunting for assets that feel resilient as AI reshapes movies, games and streaming, and global sports sit right in that crosshairs. For anyone focused on where long term attention and money may concentrate, this matters. This article breaks down three stocks tied to that story and explains how the same news affects each of them. Manchester United (MANU) Manchester United runs one...
NYSE:GAP
NYSE:GAPSpecialty Retail

Gap (GAP) Could Be 25% Undervalued Following Its Middle East Expansion Plans

Middle East partnership puts Gap in focus Gap (GAP) is drawing fresh attention after agreeing to partner with Dubai based Chalhoub Group to introduce Gap, Banana Republic, and Athleta across the UAE, Saudi Arabia, and Kuwait from 2026. See our latest analysis for Gap. Set against a year to date share price return that is down 18.74% and a 1 year total shareholder return of 6.56%, Gap’s new Middle East partnership lands while short term share price momentum has softened and the longer term...
NasdaqGS:ZD
NasdaqGS:ZDInteractive Media and Services

Ziff Davis (ZD) Reports Mixed Results, Is The Stock 11% Overvalued?

Ziff Davis (ZD) stock is in focus after the company reported second quarter 2026 results, with sales of US$286.74 million, a sharp swing in net income, and a loss from continuing operations. See our latest analysis for Ziff Davis. The earnings update and the sale of the connectivity business to Accenture for about US$1.2b have come alongside strong recent momentum in Ziff Davis, with a 90 day share price return of 28.58% and a 1 year total shareholder return of 46.86%, although the 5 year...
NasdaqGS:OPCH
NasdaqGS:OPCHHealthcare

Option Care Health (OPCH) Beat Expectations, Is The Stock Fully Priced?

Why Option Care Health stock is in focus after its latest update Option Care Health (OPCH) is drawing fresh attention after reporting second quarter 2026 results, with revenue, EBITDA, and EPS ahead of expectations, while keeping guidance unchanged and continuing investments in digital tools and infusion clinic expansion. See our latest analysis for Option Care Health. Against this backdrop, Option Care Health's recent earnings and buyback activity appear to be supporting improving sentiment...
NYSE:MET
NYSE:METInsurance

MetLife’s New US$3 Billion Buyback Could Be A Game Changer For MetLife (MET)

In early August 2026, MetLife, Inc. reported second-quarter revenue of US$19,154 million and net income of US$736 million, alongside higher diluted earnings per share from continuing operations versus a year earlier, and stronger results for the first half of 2026. On the same day, MetLife’s board authorized a new US$3.00 billion share repurchase program after completing US$2.63 billion of buybacks since April 2025, underscoring the insurer’s current emphasis on returning capital to...
NYSE:GTN
NYSE:GTNMedia

Gray Media (GTN) Stock Jumps As Political Ads Mask Leverage Risk

Gray Media stock exploded 25% higher to US$5.37 after the Q2 report, a sharp move for a regional television and media operator that has been wrestling with losses. The headline number was Q2 revenue of US$839 million, helped by US$83 million of political advertising that came in ahead of expectations. Basic earnings per share remained in loss territory, although the loss narrowed compared with recent quarters. For short term traders, the pop is the story. For longer term holders, the bigger...
NasdaqGM:ZLAB
NasdaqGM:ZLABBiotechs

Zai Lab (ZLAB) Stock May Trade At A Sales Premium Despite Stronger Broader Checks

Zai Lab stock has rebounded sharply over the short term, yet its longer term share price record and current valuation checks point to a more cautious picture for investors trying to judge what the recent move really means. Over the past 5 years, Zai Lab has fallen about 84.5%, which leaves long term holders with a material drawdown even after the recent bounce. Regulatory progress such as Orphan Drug Designation for its DLL3-targeting therapy Zocilurtatug Pelitecan can support expectations...